nChroma Bio Raises $75M to Advance Epigenetic Editing for Hepatitis B and D Cure
nChroma Bio is a biotechnology company focused on developing safe, precise in vivo genetic therapies Image credits: nChromaBio nChroma Bio was established following the merger of Chroma Medicine and Nvelop Therapeutics, combining expertise in epigenetic editing and non-viral, in vivo delivery systems. The new company announced the closing of an oversubscribed $75 million financing round, […]
Optimal Timing Determined for COVID-19 Vaccination Booster
An annual COVID-19 vaccination booster that precedes the highest anticipated prevalence in a region but is postponed in the event of a breakthrough infection was calculated to provide a 3-4-fold increase in protection from infection over less tailored seasonal recommendations, in a multi-country analysis incorporating longitudinal antibody and reinfection probabilities with regional projections of COVID-19 […]
